Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease

Advances in Alzheimer's Disease

Volumn 2, Issue , 2011, Pages 605-616

  Förster, Stefan ^a,h   Buschert, Verena C ^a   Teipel, Stefan J ^b,c   Friese, Uwe ^b,f   Buchholz, Hans Georg ^e   Drzezga, Alexander ^h   Hampel, Harald ^d   Bartenstein, Peter ^a   Buerger, Katharina ^a,g  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF OSNABRÜCK   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer's disease; cognitive intervention; cognitive stimulation; cognitive training; FDG PET; mild cognitive impairment

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ARTICLE; ASSOCIATION CORTEX; BRAIN MAPPING; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE INTERVENTION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG UPTAKE; ENERGY METABOLISM; EXERCISE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERVENTION STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PENCIL PAPER EXERCISE; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TEMPORAL CORTEX; TEMPOROOCCIPITAL ASSOCIATION CORTEX;

EID: 84865417420     PISSN: 22105727     EISSN: 22105735     Source Type: Book Series    
DOI: 10.3233/978-1-60750-793-2-605     Document Type: Article

References (40)

1. Buschert V, Bokde AL, Hampel H (2010) Cognitive intervention in Alzheimer disease. Nat Rev Neurol 6, 508-517.
2. Valenzuela M, Sachdev P (2009) Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry 17, 179-187.
3. Valenzuela MJ, Sachdev P (2006) Brain reserve, dementia: a systematic review. Psychol Med 36, 441-454.
4. Belleville S (2008) Cognitive training for persons with mild cognitive impairment. Int Psychogeriatr 20, 57-66.
5. Sitzer DI, Twamley EW, Jeste DV (2006) Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand 114, 75-90.
6. Olazaran J, Reisberg B, Clare L, Cruz I, Pena-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, Spector A, Fazio S, Bond J, Kivipelto M, Brodaty H, Rojo JM, Collins H, Teri L, Mittelman M, Orrell M, Feldman HH, Muniz R (2010) Nonpharmacological therapies in Alzheimer's disease:Asystematic review of efficacy. Dement Geriatr Cogn Disord 30, 161-178.
7. Herholz K (2003) PET studies in dementia. Ann Nucl Med 17, 79-89.
8. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334, 752-758.
9. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM (2002) Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.AmJ Psychiatry 159, 738-745.
10. Heiss WD, Kessler J, Slansky I, Mielke R, Szelies B, Herholz K (1993) Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease. Ann N Y Acad Sci 695, 327-331.
11. Small GW, Silverman DH, Siddarth P, Ercoli LM, Miller KJ, Lavretsky H, Wright BC, Bookheimer SY, Barrio JR, Phelps ME (2006) Effects of a 14-day healthy longevity lifestyle program on cognition and brain function.AmJ Geriatr Psychiatry 14, 538-545.
12. Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Moller HJ, Hampel H, Buerger K (2011) Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease:. A Pilot Study. J Alzheimers Dis, doi10.3233/JAD-2011-100999.
13. Lachman ME, Weaver SL, Bandura M, Elliott E, Lewkowicz CJ (1992) Improving memory and control belief through cognitive restructuring and self-generated strategies. J Gerontol 47, P293-P299.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
15. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114, 7-12.
16. Stern Y (2006) Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 20, 112-117.
17. Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LE, Kenowsky S, Auer SR, Elahi S, Kluger A (1999) Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Eur Arch Psychiatry Clin Neurosci 249 (3), 28-36.
18. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56, 303-308.
19. Perry RJ, Hodges JR (1999) Attention and executive deficits in Alzheimer's disease.Acritical review. Brain 122 (3), 383-404.
20. Folstein M, Folstein S, McHugh P (1975) "Mini Mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12, 189-198.
21. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1364.
22. Friston KJ, Frith CD, Liddle PF, Frackowiak RS (1991) Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 11, 690-699.
23. Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, Peters J, Bartenstein P, Lieb K, Schreckenberger M (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44, 43-50.
24. Borghammer P, Aanerud J, Gjedde A (2009) Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 46, 981-988.
25. Borghammer P, Cumming P, Aanerud J, Forster S, Gjedde A (2009) Subcortical elevation of metabolism in Parkinson's disease-A critical reappraisal in the context of global mean normalization. Neuroimage 47, 1514-1521.
26. Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, Schmidtmann I, Gerhard A, Schreckenberger M, Bartenstein P (2008) Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18 . Psychiatry Res 164, 143-153.
27. Forster S, Teipel S, Zach C, Rominger A, Cumming P, Fougere CL, Yakushev I, Haslbeck M, Hampel H, Bartenstein P, Burger K (2010) FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer s disease. J Psychiatr Res 44, 462-469.
28. Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S (2010) Functional representation of olfactory impairment in early Alzheimer's disease. J Alzheimers Dis 22, 581-591.
29. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10, 120-131.
30. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M (2001) Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 42, 548-557.
31. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42, 85-94.
32. Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A (2005) Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 64, 102-107.
33. F̈orster S, Grimmer T, Miederer I, Henriksen G, Yousefi BH, Graner P, Wester HJ, F̈orstl H, Kurz A, Dickerson BC, Bartenstein P, Drzezga A (2011) Regional expansion of hypometabolism in AD follows amyloid-deposition with temporal delay. Biological Psychiatry (in press).
34. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36, 1238-1248.
35. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30, 1104-1113.
36. Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, Ashkanian M, Vafaee M, Iversen P, Gjedde A (2008) Normalization in PET group comparison studies-the importance of a valid reference region. Neuroimage 40, 529-540.
37. Wagner G, Koch K, Schachtzabel C, Schultz CC, Sauer H, Schlosser RG (2011) Structural brain alterations in patients with major depressive disorder and high risk for suicide: Evidence for a distinct neurobiological entity? Neuroimage 54, 1607-1614.
38. Haupt S, Axmacher N, Cohen MX, Elger CE, Fell J (2009) Activation of the caudal anterior cingulate cortex due to taskrelated interference in an auditory Stroop paradigm. Hum Brain Mapp 30, 3043-3056.
39. Crottaz-Herbette S, Menon V (2006) Where and when the anterior cingulate cortex modulates attentional response: combined fMRI and ERP evidence. J Cogn Neurosci 18, 766-780.
40. Margulies DS, Kelly AM, Uddin LQ, Biswal BB, Castellanos FX, Milham MP (2007) Mapping the functional connectivity of anterior cingulate cortex. Neuroimage 37, 579-588.